We analysed primary
breast cancers by genomic DNA copy number arrays, DNA methylation, exome
sequencing, messenger RNA arrays, microRNA sequencing and reverse-phase protein
arrays. Our ability to integrate information across platforms provided key
insights into previously defined gene expression subtypes and demonstrated the
existence of four main breast cancer classes when combining data from five
platforms, each of which shows significant molecular heterogeneity. Somatic
mutations in only three genes (TP53, PIK3CA and GATA3) occurred at >10%
incidence across all breast cancers; however, there were numerous
subtype-associated and novel gene mutations including the enrichment of
specific mutations in GATA3, PIK3CA and MAP3K1 with the luminal A subtype. We
identified two novel protein-expression-defined subgroups, possibly produced by
stromal/microenvironmental elements, and integrated analyses identified
specific signalling pathways dominant in each molecular subtype including a
HER2/phosphorylated HER2/EGFR/phosphorylated EGFR signature within the
HER2-enriched expression subtype. Comparison of basal-like breast tumours with
high-grade serous ovarian tumours showed many molecular commonalities,
indicating a related aetiology and similar therapeutic opportunities. The
biological finding of the four main breast cancer subtypes caused by different
subsets of genetic and epigenetic abnormalities raises the hypothesis that much
of the clinically observable plasticity and heterogeneity occurs within, and
not across, these major biological subtypes of breast cancer.
Source: Comprehensive molecular
portraits of human breast tumours. The Cancer Genome Atlas Network; Genome
sequencing centres: Washington University in St Louis, Koboldt DC, Fulton RS,
McLellan MD, Schmidt H, Kalicki-Veizer J, McMichael JF, Fulton LL, Dooling DJ,
Ding L, Mardis ER, Wilson RK; Genome characterization centres: BC Cancer
Agency, Ally A, Balasundaram M, Butterfield YS, Carlsen R, Carter C, Chu A , Chuah E, Chun HJ, Coope RJ,
Dhalla N, Guin R, Hirst C, Hirst M, Holt RA, Lee D, Li HI, Mayo M, Moore RA,
Mungall AJ, Pleasance E, Gordon Robertson A, Schein JE, Shafiei A, Sipahimalani
P, Slobodan JR, Stoll D, Tam A, Thiessen N, Varhol RJ, Wye N, Zeng T, Zhao Y,
Birol I, Jones SJ, Marra MA; Broad Institute, Cherniack AD, Saksena G, Onofrio
RC, Pho NH, Carter SL, Schumacher SE, Tabak B, Hernandez B, Gentry J, Nguyen H,
Crenshaw A, Ardlie K, Beroukhim R, Winckler W, Getz G, Gabriel SB, Meyerson M;
Brigham & Women’s Hospital & Harvard Medical School, Chin L, Park PJ,
Kucherlapati R; University of North Carolina, Chapel Hill, Hoadley KA, Todd
Auman J, Fan C, Turman YJ, Shi Y, Li L, Topal MD, He X, Chao HH, Prat A, Silva
GO, Iglesia MD, Zhao W, Usary J, Berg JS, Adams M, Brooker J, Wu J, Gulabani A,
Bodenheimer T, Hoyle AP, Simons JV, Soloway MG, Mose LE, Jefferys SR, Balu S,
Parker JS, Neil Hayes D, Perou CM; University of Southern California/Johns
Hopkins, Malik S, Mahurkar S, Shen H, Weisenberger DJ, Triche Jr T, Lai PH,
Bootwalla MS, Maglinte DT, Berman BP, Van Den Berg DJ, Baylin SB, Laird PW;
Genome data analysis: Baylor College of Medicine, Creighton CJ, Donehower LA;
Broad Institute, Getz G, Noble M, Voet D, Saksena G, Gehlenborg N, Dicara D,
Zhang J, Zhang H, Wu CJ, Yingchun Liu S, Lawrence MS, Zou L, Sivachenko A, Lin
P, Stojanov P, Jing R, Cho J, Sinha R, Park RW, Nazaire MD, Robinson J,
Thorvaldsdottir H, Mesirov J, Park PJ, Chin L; Institute for Systems Biology,
Reynolds S, Kreisberg RB, Bernard B, Bressler R, Erkkila T, Lin J, Thorsson V,
Zhang W, Shmulevich I; Memorial Sloan-Kettering Cancer Center, Ciriello G,
Weinhold N, Schultz N, Gao J, Cerami E, Gross B, Jacobsen A, Sinha R, Arman
Aksoy B, Antipin Y, Reva B, Shen R, Taylor BS, Ladanyi M, Sander C; Oregon
Health & Science University, Anur P, Spellman PT; The University of Texas
MD Anderson Cancer Center, Lu Y, Liu W, Verhaak RR, Mills GB, Akbani R, Zhang N,
Broom BM, Casasent TD, Wakefield C, Unruh AK, Baggerly K, Coombes K, Weinstein
JN; University of California, Santa Cruz/Buck Institute, Haussler D, Benz CC,
Stuart JM, Benz SC, Zhu J, Szeto CC, Scott GK, Yau C, Paull EO, Carlin D, Wong
C, Sokolov A, Thusberg J, Mooney S, Ng S, Goldstein TC, Ellrott K, Grifford M,
Wilks C, Ma S, Craft B; NCI, Yan C, Hu Y, Meerzaman D; Biospecimen core
resource: Nationwide Children’s Hospital Biospecimen Core Resource,
Gastier-Foster JM, Bowen J, Ramirez NC, Black AD, Xpath Error Unknown Variable
Tname RE, White P, Zmuda EJ, Frick J, Lichtenberg TM, Brookens R, George MM,
Gerken MA, Harper HA, Leraas KM, Wise LJ, Tabler TR, McAllister C, Barr T,
Hart-Kothari M; Tissue source sites: ABS-IUPUI, Tarvin K, Saller C, Sandusky G,
Mitchell C; Christiana, Iacocca MV, Brown J, Rabeno B, Czerwinski C, Petrelli
N; Cureline, Dolzhansky O, Abramov M, Voronina O, Potapova O; Duke University
Medical Center, Marks JR; The Greater Poland Cancer Centre, Suchorska WM,
Murawa D, Kycler W, Ibbs M, Korski K, Spychała A, Murawa P, Brzeziński JJ, Perz
H, Laźniak R, Teresiak M, Tatka H, Leporowska E, Bogusz-Czerniewicz M, Malicki
J, Mackiewicz A, Wiznerowicz M; ILSBio, Van Le X, Kohl B, Viet Tien N, Thorp R,
Van Bang N, Sussman H, Duc Phu B, Hajek R, Phi Hung N, Viet The Phuong T, Quyet
Thang H, Zaki Khan K; International Genomics Consortium, Penny R, Mallery D,
Curley E, Shelton C, Yena P; Mayo Clinic, Ingle JN, Couch FJ, Lingle WL; MSKCC,
King TA; MD Anderson Cancer Center, Maria Gonzalez-Angulo A, Mills GB, Dyer MD,
Liu S, Meng X, Patangan M; University of California San Francisco, Waldman F,
Stöppler H; University of North Carolina, Kimryn Rathmell W, Thorne L, Huang M,
Boice L, Hill A; Roswell Park Cancer Institute, Morrison C, Gaudioso C, Bshara
W; University of Miami, Daily K, Egea SC, Pegram MD, Gomez-Fernandez C;
University of Pittsburgh, Dhir R, Bhargava R, Brufsky A; Walter Reed National
Military Medical Center, Shriver CD, Hooke JA, Leigh Campbell J, Mural RJ, Hu
H, Somiari S, Larson C, Deyarmin B, Kvecher L, Kovatich AJ; Disease working
group, Ellis MJ, King TA, Hu H, Couch FJ, Mural RJ, Stricker T, White K,
Olopade O, Ingle JN, Luo C, Chen Y, Marks JR, Waldman F, Wiznerowicz M, Bose R,
Chang LW, Beck AH, Maria Gonzalez-Angulo A; Data coordination centre, Pihl T,
Jensen M, Sfeir R, Kahn A, Chu A ,
Kothiyal P, Wang Z, Snyder E, Pontius J, Ayala B, Backus M, Walton J, Baboud J,
Berton D, Nicholls M, Srinivasan D, Raman R, Girshik S, Kigonya P, Alonso S,
Sanbhadti R, Barletta S, Pot D; Project team: National Cancer Institute, Sheth
M, Demchok JA, Mills Shaw KR, Yang L, Eley G, Ferguson ML, Tarnuzzer RW, Zhang
J, Dillon LA, Buetow K, Fielding P; National Human Genome Research Institute,
Ozenberger BA, Guyer MS, Sofia HJ, Palchik JD. Nature. 2012 Sep 23.
Free paper available at:
http://www.nature.com/nature/journal/vaop/ncurrent/pdf/nature11412.pdf
Aucun commentaire:
Enregistrer un commentaire